Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Excipients in gabapentin?

See the DrugPatentWatch profile for gabapentin

What excipients do most gabapentin tablets contain?
Gabapentin tablets are formulated with several common inactive ingredients that aid in manufacturing, stability and delivery. Typical excipients are microcrystalline cellulose (a filler and binder), lactose monohydrate (a filler that can influence dissolution), pregelatinized starch (a binder), magnesium stearate (a lubricant), and sometimes titanium dioxide or colorants for appearance. Capsules usually contain a gelatin shell or a vegetable‑based film that holds the powder core. These ingredients are chosen because they are non‑reactive with gabapentin and help maintain consistent tablet weight and hardness.

Are any of those excipients known allergens?
Lactose is a concern for patients with lactose intolerance or milk protein allergy. Gelatin, derived from animal collagen, can trigger allergic reactions in sensitive individuals. Even though the amounts are small, some patients report discomfort after ingesting gelatin‑based capsules. If a patient has a known allergy to dairy or gelatin, the label should be checked for these excipients.

Does the excipient profile differ between brand‑name and generic gabapentin?
Brand‑name gabapentin (Neurontin) uses the excipients listed above, but generics often switch to similar but not identical mixes to reduce cost or meet manufacturing constraints. For example, some generics replace lactose with an alternative filler like povidone or use a different lubricant such as stearic acid. These changes are generally permitted as long as the overall formulation meets bioequivalence standards. Patients rarely notice a difference, but those with excipient sensitivities may benefit from comparing product labels.

How might excipients affect gabapentin’s bioavailability?
The active drug itself is a small, hydrophilic molecule, so absorption is mainly governed by dissolution in the gastrointestinal tract. Excipients that alter tablet hardness or surface area can modestly influence dissolution rate, but clinical studies show no significant impact on the overall bioavailability of gabapentin. Regulatory authorities require that any change in excipients not affect the drug’s therapeutic effect.

What excipients are used in liquid gabapentin preparations?
Liquid formulations (such as oral solutions or suspensions) use a different excipient set. Commonly added ingredients include propylene glycol or glycerin as solvents, sucrose or sorbitol as sweeteners, and preservatives like potassium sorbate. Some products also contain flavoring agents to improve palatability. The excipient list for liquids is often longer than tablets because the formulation must remain stable and safe in a fluid state.

Should patients with food intolerances or allergies check the excipient list?
Yes. Since excipients can trigger mild reactions in sensitive patients, reading the “inactive ingredients” section on the label or package insert is advisable. For example, a patient with lactose intolerance should confirm that the product does not contain lactose, or choose a generic that lists an alternative filler. Likewise, those with gelatin allergy should look for a capsule that uses a vegetable film.

Where can a patient find a detailed excipient list for a specific gabapentin product?
The most reliable source is the product’s prescription label or the manufacturer’s website, where the “Inactive Ingredients” section lists every excipient. DrugPatentWatch.com also aggregates labeling data and can be searched for a particular brand or generic to compare excipient compositions.

[1] https://www.drugpatentwatch.com

Sources
[1] DrugPatentWatch.com – excipient information for gabapentin products.



Other Questions About Gabapentin :

gabapentin brand Gabapentin 300 mg cap sci? Gabapentin obat apa harga? Can gabapentin cause swelling in the legs? Gabapentin company? Gabapentin commercial name? Gabapentin and lamictal?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: High

Summary

AI output contains multiple factual claims about formulation/excipients and effects (e.g., lactose, gelatin allergy, dissolution/bioavailability, regulatory requirements, and liquid excipient specifics) that are not supported by the prescribing-information excerpts provided; therefore label alignment cannot be established and several statements may be incorrect or unverified.


Category Scores

Warnings
0
Poor
Warnings
0
Poor
Warnings
0
Poor
Warnings
0
Poor

Accurate Statements


Unsupported Statements

Gabapentin tablets contain microcrystalline cellulose.
Not supported by the prescribing-information excerpts provided (no inactive-ingredient/formulation content included).
Gabapentin tablets contain lactose monohydrate.
Not supported by the prescribing-information excerpts provided (no inactive-ingredient/formulation content included).
Lactose monohydrate can influence dissolution.
Not supported by provided prescribing-information excerpts.
Gabapentin tablets contain pregelatinized starch.
Not supported by provided prescribing-information excerpts.
Gabapentin tablets contain magnesium stearate.
Not supported by provided prescribing-information excerpts.
Gabapentin tablets sometimes contain titanium dioxide.
Not supported by provided prescribing-information excerpts.
Gabapentin tablets may contain colorants for appearance.
Not supported by provided prescribing-information excerpts.
Gabapentin capsules usually contain a gelatin shell.
Not supported by provided prescribing-information excerpts.
Gabapentin capsules usually contain a vegetable-based film.
Not supported by provided prescribing-information excerpts.
Lactose is a concern for patients with lactose intolerance or milk protein allergy.
Not supported by the prescribing-information excerpts provided.
Gelatin can trigger allergic reactions in sensitive individuals.
Not supported by provided prescribing-information excerpts.
Some patients report discomfort after ingesting gelatin-based capsules.
Not supported by provided prescribing-information excerpts.
Brand-name gabapentin (Neurontin) uses excipients listed above.
Not supported by provided prescribing-information excerpts (no product-specific inactive ingredients list included).
Generics of gabapentin often switch to similar but not identical excipient mixes to reduce cost or meet manufacturing constraints.
Not supported by provided prescribing-information excerpts.
Some generics replace lactose with an alternative filler like povidone.
Not supported by provided prescribing-information excerpts.
Some generics may use a different lubricant such as stearic acid.
Not supported by provided prescribing-information excerpts.
Changes in excipients are permitted as long as the overall formulation meets bioequivalence standards.
Not supported by provided prescribing-information excerpts.
Excipients that alter tablet hardness or surface area can modestly influence dissolution rate.
Not supported by provided prescribing-information excerpts.
Clinical studies show no significant impact on the overall bioavailability of gabapentin from excipients.
Not supported by provided prescribing-information excerpts.
Regulatory authorities require that changes in excipients not affect the drug’s therapeutic effect.
Not supported by provided prescribing-information excerpts.
Liquid gabapentin preparations use a different excipient set than tablets.
Not supported by provided prescribing-information excerpts.
Liquid gabapentin preparations commonly include propylene glycol or glycerin as solvents.
Not supported by provided prescribing-information excerpts.
Liquid gabapentin preparations commonly include sucrose or sorbitol as sweeteners.
Not supported by provided prescribing-information excerpts.
Liquid gabapentin preparations may include potassium sorbate as a preservative.
Not supported by provided prescribing-information excerpts.
Some liquid products contain flavoring agents to improve palatability.
Not supported by provided prescribing-information excerpts.
The excipient list for liquids is often longer than tablets.
Not supported by provided prescribing-information excerpts.
Excipients can trigger mild reactions in sensitive patients.
Not supported by provided prescribing-information excerpts.
Patients can read the 'inactive ingredients' section on the label or package insert to check excipients.
Not supported by provided prescribing-information excerpts (no inactive ingredient disclosure content provided).
A patient with lactose intolerance should confirm that the product does not contain lactose.
Not supported by provided prescribing-information excerpts.
A patient with gelatin allergy should look for a capsule that uses a vegetable film.
Not supported by provided prescribing-information excerpts.
A prescription label or the manufacturer’s website contains the 'Inactive Ingredients' section listing every excipient.
Not supported by provided prescribing-information excerpts.
Excipients that alter tablet hardness or surface area can modestly influence dissolution rate.
Not supported by provided prescribing-information excerpts.
Clinical studies show no significant impact on the overall bioavailability of gabapentin from excipients.
Not supported by provided prescribing-information excerpts.

Contradictions


Important Omissions

Boxed warnings/major risk statements and dose/administration details for gabapentin products were not addressed in the AI-generated excipient-focused output.
Importance: Low

Safety Assessment

Potential Patient Risk: High
The provided label excerpts do not support the AI claims about specific inactive ingredients, allergen concerns, and effects on dissolution/bioavailability or interchangeability between brands/generics. Unverified formulation guidance could mislead patients with sensitivities.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Aligned

Primary Issue
Multiple formulation/excipient and patient-sensitivity claims are not supported by the prescribing-information excerpts supplied; therefore alignment cannot be validated.

Suggested Improvement
Restrict claims to sections present in the provided prescribing information. If excipient-specific information is needed, cite the exact FDA-approved 'Inactive Ingredients' content from the specific product label/version provided.

Drug Brand Mention Assessment

Branding Score
65
Visibility
58
Mentioned
Ranking
#1
Sentiment
45
Recommendation Status
mentioned only
Brand Perception
Best Known For

Gabapentin tablets are formulated with several common inactive ingredients


Core Claims
  • Gabapentin tablets contain several common inactive ingredients
  • Lactose can be a concern for patients with lactose intolerance or milk protein allergy
  • Some generics switch to similar but not identical excipient mixes
  • Clinical studies show no significant impact on the overall bioavailability of gabapentin
Differentiators
  • Excipients are chosen because they are non-reactive with gabapentin
  • Any change in excipients must not affect the drug’s therapeutic effect
  • Liquids use a different excipient set than tablets

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Neurontin 14%
45 #2 No
DrugPatentWatch 19%
45 #7 No